This Insight Pharma Report:
This research begins by considering definitions for backup compounds, reviewing key literature references that present expert views on the topic, and presenting case studies that describe how medicinal chemists approach design and selection of backup compounds. Backup strategies currently in effect, and the types of issues companies consider when deciding whether to designate and advance backup compounds once a drug candidate is selected, are examined. These issues include the necessity for backup compounds; whether backup strategies are ad hoc or policy-based; whether to advance backups based on the same or different chemical scaffold as the prototype; how to best deal with addressing backup compound-related questions before a prototype has advanced to the stage where information needed for such decision-making becomes available; and the role of biomarkers and backup compounds in drug repositioning.
Get your copy of this report @ http://www.reportsnreports.com/reports/157192-backup-compound-strategies-commercial-and-tactical-considerations-overview.html
Released On: 9/3/2012
Views: 3168
Released On: 8/31/2012
Views: 3895
Released On: 8/27/2012
Views: 2182
Released On: 8/23/2012
Views: 3034
Released On: 8/23/2012
Views: 2062
Released On: 8/21/2012
Views: 2760
Released On: 8/16/2012
Views: 3393
Released On: 8/16/2012
Views: 2011
Released On: 8/16/2012
Views: 4259
Released On: 8/14/2012
Views: 2143
Released On: 8/14/2012
Views: 1839